Cargando…

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

OBJECTIVE: To determine the construct and criterion validity of the British Isles Lupus Assessment Group 2004 (BILAG-2004) index for assessing disease activity in systemic lupus erythematosus (SLE). METHODS: Patients with SLE were recruited into a multicenter cross-sectional study. Data on SLE disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yee, Chee-Seng, Farewell, Vernon, Isenberg, David A, Rahman, Anisur, Teh, Lee-Suan, Griffiths, Bridget, Bruce, Ian N, Ahmad, Yasmeen, Prabu, Athiveeraramapandian, Akil, Mohammed, McHugh, Neil, D'Cruz, David, Khamashta, Munther A, Maddison, Peter, Gordon, Caroline
Formato:	Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2007
Materias:	Life and Medical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659367/ https://www.ncbi.nlm.nih.gov/pubmed/18050213 http://dx.doi.org/10.1002/art.23130

Ejemplares similares

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity
por: Yee, Chee-Seng, et al.
Publicado: (2009)

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
por: Yee, Chee-Seng, et al.
Publicado: (2011)

The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally
por: Yee, Chee-Seng, et al.
Publicado: (2012)

Numerical scoring for the BILAG-2004 index
por: Yee, Chee-Seng, et al.
Publicado: (2010)

Numerical scoring for the Classic BILAG index
por: Cresswell, Lynne, et al.
Publicado: (2009)

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
por: McCarthy, Eoghan M, et al.
Publicado: (2018)

The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients
por: Yee, Chee-Seng, et al.
Publicado: (2012)

Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2016)

Flares in patients with systemic lupus erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2020)

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine
por: Reynolds, John A, et al.
Publicado: (2022)

What Does It Mean to Be a British Isles Lupus Assessment Group–Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III Trials
por: Furie, Richard, et al.
Publicado: (2021)

The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients
por: Yee, Chee-Seng, et al.
Publicado: (2022)

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
por: Luo, Weike, et al.
Publicado: (2022)

Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study
por: Mahmoud, Khaled, et al.
Publicado: (2021)

Literature review of lupus nephritis From the Arabian Gulf region
por: Al-Shujairi, Arwa, et al.
Publicado: (2022)

Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1
por: Lewis, Myles J., et al.
Publicado: (2016)

Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR)
por: Dyball, Sarah, et al.
Publicado: (2021)

Imaging Assessment of Cardiovascular Disease in Systemic Lupus Erythematosus
por: Croca, Sara C., et al.
Publicado: (2012)

Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin
por: Manson, Jessica J, et al.
Publicado: (2014)

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus
por: Bakshi, Jyoti, et al.
Publicado: (2022)

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
por: Bruce, Ian N, et al.
Publicado: (2015)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Correlated multistate models for multiple processes: an application to renal disease progression in systemic lupus erythematosus
por: O’Keeffe, Aidan G., et al.
Publicado: (2018)

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
por: Hanly, John G., et al.
Publicado: (2019)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016)

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus
por: Furie, Richard, et al.
Publicado: (2017)

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
por: Manson, Jessica J, et al.
Publicado: (2009)

Editorial: Cutting edge in systemic lupus erythematosus
por: D’Cruz, David P., et al.
Publicado: (2017)

Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
por: Merrill, Joan T, et al.
Publicado: (2018)

Topical calcineurin inhibitors in systemic lupus erythematosus
por: Lampropoulos, Christos E, et al.
Publicado: (2010)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients
por: Isenberg, D., et al.
Publicado: (2017)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

The role of cardiac magnetic resonance imaging in the assessment of systemic lupus erythematosis (SLE)
por: Norman, Wendy, et al.
Publicado: (2009)

Towards Precision Medicine in Systemic Lupus Erythematosus
por: Lever, Elliott, et al.
Publicado: (2020)

Clinical observation: are nightmares a manifestation of neuropsychiatric lupus?
por: D’Cruz, David P, et al.
Publicado: (2022)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
por: Farinha, Filipa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vnngsrmha9nsi3qijakb77ttc8